S. Luchetti

Medicine & Life Sciences

1. Multiple Sclerosis 100%
2. Purinergic P2X7 Receptors 53%
3. Pathology 50%
4. Histamine Receptors 50%
5. Biosynthetic Pathways 45%
6. Autopsy 39%
7. Brain 38%
8. Mood Disorders 36%
9. Brain Diseases 35%
10. Prefrontal Cortex 34%
11. Single Nucleotide Polymorphism 31%
12. Parkinson Disease 31%
13. 1-((5-chloro-1H-indol-2-yl)carbonyl)-4-methylpiperazine 30%
14. Microglia 28%
15. Steroids 28%
16. Major Depressive Disorder 26%
17. Gyrus Cinguli 25%
18. Cohort Studies 25%
19. Dehydroepiandrosterone 22%
20. Inflammation 22%
21. Messenger RNA 21%
22. Brain-Derived Neurotrophic Factor 19%
23. Protein-Tyrosine Kinases 17%
24. Dehydroepiandrosterone Sulfate 15%
25. Monocytes 12%
26. Bipolar Disorder 12%
27. alcohol sulfotransferase 11%
28. Macrophages 11%
29. Basal Ganglia 10%
30. Histamine 10%
31. Ketosteroids 10%
32. Chronic Progressive Multiple Sclerosis 10%
33. In Vitro Techniques 9%
34. Relapsing-Remitting Multiple Sclerosis 9%
35. Serotonin 9%
36. steroidogenic acute regulatory protein 9%
37. 11-beta-Hydroxysteroid Dehydrogenases 9%
38. Primary Cell Culture 9%
39. Demyelinating Diseases 8%
40. Synucleins 8%
41. Therapeutics 7%
42. Aminobutyrates 7%
43. Cortisone 7%
44. Oligodendroglia 7%
45. Intraventricular Infusions 7%
46. Gray Matter 7%
47. Rotenone 7%
48. Netherlands 7%
49. Frontal Lobe 7%
50. Astrocytes 6%